SIRT6 haploinsufficiency but not complete SIRT6 loss induced IGFBP2 expression followed by IGF-1R and AKT signaling activation in BRAFV600E melanoma cells, leading to MAPK inhibitor resistance. This evidence concerns the gene SIRT6 and melanoma.